NEW YORK (GenomeWeb) – Insilico Medicine said this week that it will integrate unspecified data assets as well as the staff of InSilico Screen, a Belgian bioinformatics company that provides tools for dynamic signaling modelling and scalable molecular simulations.

Under the terms of the agreement, InSilico Screen Founder and CEO Quentin Vanhaelen will join Insilico Medicine as the head of the so-called "almost human" team. He will split his time between Baltimore, where InSilico Medicine has an office, and Brussels, where InSilico Screen is located.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jul
10
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Jul
11
Sponsored by
Genomenon

This webinar will discuss an approach for automating variant classification based on the American College of Medical Genetics and Genomics guidelines.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.